^
    Apply
    Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00085124)
    Phase 3
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    05/30/2024
    Initiation :
    12/01/2003
    Primary completion :
    06/01/2007
    BCL2
    |
    cytarabine • daunorubicin • Genasense (oblimersen)
    Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00049374)
    Phase 2
    University of Maryland, Baltimore
    Completed
    Last update posted :
    10/17/2019
    Initiation :
    09/01/2002
    Primary completion :
    01/01/2006
    Completion :
    01/01/2006
    BCL2
    |
    dexamethasone • thalidomide • Genasense (oblimersen)
    Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00039117)
    Phase 1
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    12/04/2015
    Initiation :
    04/01/2002
    Primary completion :
    09/01/2003
    BCL2
    |
    cytarabine • daunorubicin • Genasense (oblimersen)